GAT-1102

N/A

Report date: 2025/01/26 19:02:21
NME

Base Information

Drug NameGAT-1102
Drug Alias Namedualsteric cannabinoid CB1 positive allosteric modulator/CB2 agonist (Indiana University/Northeastern University)dualsteric cannabinoid CB1 positive allosteric modulator/CB2 agonist (Indiana University/Northeastern University)GAT-1102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor agonistsCannabinoid CB1 receptor agonists
TargetsCannabinoid CB1 receptorCannabinoid CB2 receptor
Therapy Area/IndicationsGlaucomaNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIndiana University
China Registration ClassN/A

Develop Information

Active CompaniesNortheastern UniversityIndiana University
Inactive CompaniesN/A
Active IndicationsGlaucomaNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A